Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics